INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Similar documents
Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012

ExtraintestinalManifestations of IBD

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Crohn s Disease. Resident Lecture 1/17/19

What Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy?

INFLAMMATORY BOWEL DISEASE

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

What do we need for diagnosis of IBD

Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease

What is Crohn's disease?

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

Inflammatory Bowel Disease Ischemic bowel disease

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

Medical therapies and IBD

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

SURGICAL MANAGEMENT OF ULCERATIVE COLITIS

Digestion: Small and Large Intestines Pathology

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION

P a g e 1. Inflammatory Bowel Disease Guidelines

Inflammatory Bowel Disease

UNDERSTANDING CROHN S DISEASE

Understanding Your Benefits and Risks

Chapter 5: Common Digestive Problems from The Kansas State University Human Nutrition (HN 400) Flexbook by Brian Lindshield is in the public domain

Year 2002 Paper two: Questions supplied by Jo 1

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

CROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.

Small Bowel and Colon Surgery

Clinical Manifestations of Gastrointestinal Disorders. Awni Taleb Abu sneineh

What is Inflammatory Bowel Disease (IBD)?

Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.

SURVIVING & THRIVING. A Guide to Living with Crohn s Disease or Ulcerative Colitis.

What is IBD and Why Me?

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

Inflammatory Bowel Disease

INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE

Ulcerative Colitis. ulcerative colitis usually only affects the colon.

Inflammatory Bowel Disease and Surgery: What You Should Know

Inflammatory Bowel Disease. Your Illness and Its Treatment

Understanding Your Benefits and Risks

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Judith Collins, MD Assoc Professor of Gastroenterology & Hepatology Inflammatory Bowel Disease Program, OHSU

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Understanding Learning is the first step to getting help.

3/22/2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease Objectives: Appendicitis. Lemone and Burke Chapter 26

Efficacy and Safety of Treatment for Pediatric IBD

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Outcomes of immunosuppressors and biologic drugs in inflammatory bowel diseases: a real life experience

Understanding Inflammatory Bowel Diseases (IBD):

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group.

Lower Gastrointestinal Tract KNH 406

How to manage your IBD patient: Tips for diagnosis and care

Crohn s Disease. How does Crohn s disease affect the intestinal tract?

GASTROENTEROLOGY. Official Publication of the American Gastroenterological Association. CoPYRIGHT 1975 THE WILLIAMS & WILKINS Co.

Selby Inflamm Bowel Dis. 2008:14:

Pharmacology of Combined Mesalzine and Rifaximin Therapy for Inflammatory Bowel Disease

Corporate Medical Policy

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

F A M N O P R S ! D !

Who gets EIMs? Dr Tim Orchard St Mary s Hospital & Imperial College London

Treating Crohn s and Colitis in the ASC

ENTYVIO (VEDOLIZUMAB)

Surgery and Crohn s. Crohn s Disease 70 % Why Operate? Complications of Disease. The Gastrointestinal Tract. Surgery for Inflammatory Bowel Disease

study was undertaken to assess the epidemiology, course and outcome of UC patients attending a hospital in Jordan.

Efficacy and Safety of Treatment for Pediatric IBD

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I.

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Ali Keshavarzian MD Rush University Medical Center

A Case of Inflammatory Bowel Disease

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

What is Crohn's disease?

UNDERSTANDING ULCERATIVE COLITIS

Surgery for Inflammatory Bowel Disease

A PARENT S GUIDE TO INFLAMMATORY BOWEL DISEASE

CROHN S DISEASE AND ULCERATIVE COLITIS

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

Diarrhoea for the Acute Physician

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases

Slide Kit developed and PowerPoint and Monograph edited by Daniel H. Present, MD Clinical Professor of Medicine Mt. Sinai School of Medicine

ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה

An Unusual Complication of Crohn s Disease. Dr Gerald Busuttil Mr Debono s Firm Surgical Grand Round 25 th November 2008

VOLUME - X ISSUE - LX NOV / DEC 2013

The Role of Ultrasound in the Assessment of Inflammatory Bowel Disease

Good Morning! Thursday, February 5, 2015

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Chapter 34. Nursing Care of Patients with Lower Gastrointestinal Disorders

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

Use of extrapolation in small clinical trials:

Transcription:

INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related but different diseases: Ulcerative colitis Crohn s disease

WHAT IBD IS NOT IBD is sometimes confused with: Irritable bowel syndrome (IBS) Diverticulitis Colitis

INTESTINES: NORMAL STATE Protective immune cells are present in intestinal wall Immune system turns on and off to fight harmful substances like bacteria and viruses that pass through intestines

Microflora distribution in the GI tract Oral cavity - 10 7 to 10 8 Stomach - 0 to 10 3 Duodenum - < 10 8 Jejunum - < 10 3 to 10 5 Ileum - < 10 5 to 10 7 Large intestine - 10 10 to 10 12 Oral cavity Esophagus Stomach Large intestine Small intestine Stool - 10 10 to 10 12

WHAT HAPPENS IN IBD? The immune system is activated by some unidentified factor The immune system does not turn off: Uncontrolled inflammation Attack on normal intestinal cells

Multifactorial Basis of IBD Immune factors Nonspecific inflammation Tissue injury Genetic factors Environmental factors Restitution and repair Elson CO et al. In: Proceedings of V International Symposium on Inflammatory Bowel Diseases, 1998.

Chronic Inflammation: Imbalance Between Mediators IFN-γ IL-12 IL-1β TNF-α IL-8 IL-1ra IL-4/IL-13 IL-10 TGF-β Pro-inflammatory Anti-inflammatory

HOW COMMON IS IBD? More than 1 million cases estimated in the United States: Ulcerative colitis: 50% Crohn s disease: 50% New cases diagnosed at a rate of 10 cases per 100,000 people

SCOPE OF THE PROBLEM Chronic lifelong diseases Periods of active disease alternating with periods of disease control: Other conditions can cause symptoms that mimic those of IBD Complications can develop Surgery frequently required

ULCERATIVE COLITIS Inflammation of the inner lining of the colon (mucosa) Only the colon is involved- starts in the rectum and spreads up the colon in continuous pattern Curable by surgery- removal of the colon

Gastrointestinal Tract Esophagus Small Intestine Stomach Colon Appendix Rectum

Disease Distribution at Presentation n=1116 37% 46% 17% Farmer RG, Easley KA, Ranking GB. Dig Dis Sci 1993;38(6):1137-1146.

ULCERATIVE COLITIS: SYMPTOMS Diarrhea Rectal bleeding Rectal urgency Abdominal cramps Fever

Normal Colonic Mucosa

UC: Transition Point

Disease Distribution at Presentation n=1116 37% 46% 17% Farmer RG, Easley KA, Ranking GB. Dig Dis Sci 1993;38(6):1137-1146.

ULCERATIVE COLITIS: SYMPTOMS Diarrhea Rectal bleeding Rectal urgency Abdominal cramps Fever

UC Natural History Patients with UC (%). 100% 80% 60% 40% 20% Moderate-High Activity (20%) Low Activity (30%) No Symptoms (50%) Colectomy Rate (%) 40% 30% 20% 10% 10% 23% 31% 0% Disease Activity 0% 0 5 10 15 20 Years Hendriksen C, Kreiner S, Binder V. Gut 1985;26:158-163.

CROHN S DISEASE Inflammation can involve all layers of the intestinal wall Can involve any part of the intestines from mouth to rectum with skip lesions- areas in between disease can be normal Usually comes back after surgery

Gastrointestinal Tract Esophagus Small Intestine Stomach Colon Appendix Rectum

Locations in the GI Tract Most Often Affected 40% Large and small intestine 25% Large intestine only 30% Small intestine only 5% Stomach and small intestine

CROHN S DISEASE: SYMPTOMS Same as those for ulcerative colitis Weight loss Fistulas- abnormal connection between intestine and other organs Abscess- collection of pus Strictures- areas of narrowing

Crohn s Disease Complications: Fistulas Small Intestine Fistula Colon Fistula A tunnel between two sections of the intestines or between the intestines and other organs, including the skin

Crohn s Disease Complications: Abscesses A localized collection of pus within the tissue of the GI tract Stomach Large Intestine (Colon) Abscess from a fissure in the small intestine into the peritoneal cavity Small Intestine

Complications of CD: Fistulas Abdominal Fistula Perianal Fistula

Cumulative Probability of Surgical Intervention in CD 100 80 Probability (%) 60 40 20 ±2 SD 0 0 D 2 5 8 11 14 17 20 Years Events (no.) 122 26 15 7 7 4 8 1 8 2 2 2 3 2 1 Munkholm P, et al. Gastroenterology. 1993;105:1716.

Extraintestinal Manifestations Skin disorders: Erythema nodosum Pyoderma gangrenosum Joint disorders: Peripheral arthritis Sacroiliitis Ankylosing spondylitis Ocular disorders: Iritis, uveitis, and episcleritis

Extraintestinal Manifestations Hepatobiliary: Gallstones Primary sclerosing cholangitis (PSC) Cholangiocarcinoma Renal: Renal stones Amyloidosis Other manifestations: Aphthous stomatitis Hypercoagulable state

Episcleritis

Peripheral Arthritis

Erythema Nodosum

Pyoderma Gangrenosum

Treatment of IBD

Goals of Treatment Induce response/remission Maintain response/remission Heal mucosal lining Prevent or cure complications (eg, fistulas) Improve quality of life Restore and maintain nutrition Limit surgery

Treatment Options for IBD 5-ASA agents Antibiotics Steroids Immunomodulators: 6-MP/azathioprine Methotrexate Biologic agents: Anti-TNF agents Natalizumab